Sunshine Biopharma Inc SBFM shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
Toxicity studies using non-transformed human cells showed that these mRNA molecules had little or no cytotoxic effects. Sunshine Biopharma said these new mRNA molecules are readily adaptable for delivery into patients using the mRNA vaccine technology. The company expects to file a patent application in connection with these results soon.
Sunshine Biopharma is a pharmaceutical company focused on researching, developing and commercializing oncology and antiviral drugs.
See Also: Why System1 Stock Is Surging Today
SBFM 52-Week Range: $0.04 - $4.99
The stock was up 173% at $6.17 at time of publication, according to data from Benzinga Pro.
Photo: Belova59 from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
